BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23527559)

  • 1. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.
    Cheng F; Li W; Wu Z; Wang X; Zhang C; Li J; Liu G; Tang Y
    J Chem Inf Model; 2013 Apr; 53(4):753-62. PubMed ID: 23527559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug events: database construction and in silico prediction.
    Cheng F; Li W; Wang X; Zhou Y; Wu Z; Shen J; Tang Y
    J Chem Inf Model; 2013 Apr; 53(4):744-52. PubMed ID: 23521697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based inference methods for drug repositioning.
    Chen H; Zhang H; Zhang Z; Cao Y; Tang W
    Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.
    Sawada R; Iwata H; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Dec; 55(12):2717-30. PubMed ID: 26580494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual affinity fingerprints for target fishing: a new application of Drug Profile Matching.
    Peragovics Á; Simon Z; Tombor L; Jelinek B; Hári P; Czobor P; Málnási-Csizmadia A
    J Chem Inf Model; 2013 Jan; 53(1):103-13. PubMed ID: 23215025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration and analysis of drug modes of action through feature integration.
    Xin M; Fan J; Liu M; Jiang Z
    Mol Biosyst; 2017 Jan; 13(2):425-431. PubMed ID: 28092388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug effect prediction by polypharmacology-based interaction profiling.
    Simon Z; Peragovics A; Vigh-Smeller M; Csukly G; Tombor L; Yang Z; Zahoránszky-Kohalmi G; Végner L; Jelinek B; Hári P; Hetényi C; Bitter I; Czobor P; Málnási-Csizmadia A
    J Chem Inf Model; 2012 Jan; 52(1):134-45. PubMed ID: 22098080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.
    Wu Z; Cheng F; Li J; Li W; Liu G; Tang Y
    Brief Bioinform; 2017 Mar; 18(2):333-347. PubMed ID: 26944082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting unintended effects of drugs based on off-target tissue effects.
    Kim D; Lee J; Lee S; Park J; Lee D
    Biochem Biophys Res Commun; 2016 Jan; 469(3):399-404. PubMed ID: 26626077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-target interaction prediction by integrating chemical, genomic, functional and pharmacological data.
    Yang F; Xu J; Zeng J
    Pac Symp Biocomput; 2014; ():148-59. PubMed ID: 24297542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive in silico off-target profiling in drug discovery.
    Schmidt F; Matter H; Hessler G; Czich A
    Future Med Chem; 2014 Mar; 6(3):295-317. PubMed ID: 24575966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules.
    Dutta D; Das R; Mandal C; Mandal C
    J Chem Inf Model; 2018 Jan; 58(1):68-89. PubMed ID: 29243930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug indications based on chemical interactions and chemical similarities.
    Huang G; Lu Y; Lu C; Zheng M; Cai YD
    Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space.
    Dai W; Liu X; Gao Y; Chen L; Song J; Chen D; Gao K; Jiang Y; Yang Y; Chen J; Lu P
    Comput Math Methods Med; 2015; 2015():275045. PubMed ID: 26078775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H; Sawada R; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.